N/A
Completed N=27
Cannabis Use in Cancer Patients
Solid Tumor, Adult
Source: ClinicalTrials.gov NCT03617692 ↗
Enrolled (actual)
27
Serious AEs
0.0%
Results posted
Jun 2024
Primary outcomePrimary: Likelihood of Accruing Participants: Feasibility of Enrollment — 27; 24 Participants
Summary
The goal of this study is to determine the feasibility of a human observational study of orally administered cannabis use among cancer patients.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Likelihood of Accruing Participants: Feasibility of Enrollment |
27; 24 | — |
Eligibility Criteria
Inclusion Criteria
In order to be eligible to participate in this study, an individual must meet all of the following criteria:
- Provision to sign and date the consent form.
- Stated willingness to comply with all study procedures and be available for the duration of the study.
- Be a female or male aged at least 21 years.
- Have a diagnosis of any solid tumor type who has or is undergoing either curative or palliative treatment
- Have intent or interest to use cannabis to treat their symptoms.
Exclusion Criteria
An individual who meets any of the following criteria will be excluded from participation in this study:
- Report of other non-prescription drug use, such as cocaine, heroin, methamphetamine in the past 60 days
- Actively seeking or in treatment for any substance use disorder
- Acute illness other than cancer that could affect cognition or compliance per the decision of the study M.D.
- Premenopausal females who are pregnant or trying to become pregnant. Note that pregnancy testing will not be required.
- A Telephone Interview for Cognitive Status (TICS) score indicating moderate or severe cognitive impairment at screening
Data sourced from ClinicalTrials.gov (NCT03617692). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.